4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-038592
CEO and CFO bought 2,500 shares at $7.97 ($19,925)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2023-10-26 | Purchase | +2,500 | $7.97 | $19,925 | 5,304,177 | D |
| Open-market purchases · 2,500 sh · avg $7.97 · $19,925 | |||||||
Loading xslF345X05/ownership.xml…